V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007390 | 240004593 | 1.6 | 60 | Curative (C) | 2017-06-05 | 2017-06-13 | INTERLACE TRIAL | N | N | 240033385 | INTERLACE TRIAL |
| 240007391 | 240010563 | 1.64 | 70 | null | null | 2015-09-09 | DA 3 + 10 | N | N | 240033387 | DA |
| 240007392 | 240004594 | 1.7 | 61.9 | Palliative (P) | 2013-07-28 | 2014-02-15 | Hydroxycarbamide | 01 | N | 240033388 | HYDROXYCARBAMIDE |
| 240007393 | 240004595 | 1.64 | 75.8 | Disease modification (D) | null | 2013-04-12 | CHLORAMBUCIL + RITUXIMAB | N | N | 240033393 | CHLORAMBUCIL + RITUXIMAB |
| 240007394 | 240004596 | null | null | Palliative (P) | 2013-07-11 | 2013-07-16 | R Chlorambucil | N | null | 240033396 | CHLORAMBUCIL + RITUXIMAB |
| 240007395 | 240004596 | 1.77 | 69 | Disease modification (D) | null | 2016-08-19 | BENDAMUSTINE | N | N | 240033396 | BENDAMUSTINE |
| 240007396 | 240004597 | 1.57 | 65 | Palliative (P) | 2017-11-08 | 2017-11-08 | CHLORAMBUCIL + RITUXIMAB | N | N | 240033400 | CHLORAMBUCIL + RITUXIMAB |
| 240007397 | 240004598 | 1.78 | 54 | Palliative (P) | 2014-02-14 | 2014-04-03 | Carboplatin + Etoposide iv&po | N | N | 240033402 | CARBOPLATIN + ETOPOSIDE |
| 240007398 | 240004598 | 1.68 | 67 | Adjuvant (A) | 2014-08-13 | 2014-08-13 | Hydroxycarbamide | 02 | N | 240033402 | HYDROXYCARBAMIDE |
| 240007399 | 240004599 | 1.67 | 75.2 | Palliative (P) | 2015-06-26 | 2015-07-03 | Bevacizumab+Carbo+Pacliaxel | N | N | 240033408 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007400 | 240004600 | 1.63 | 64.7 | null | 2013-08-04 | 2013-08-05 | Chlorambucil | N | N | 240033410 | CHLORAMBUCIL |
| 240007401 | 240004601 | 1.76 | 102 | Palliative (P) | 2013-07-21 | 2013-08-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033411 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007402 | 240010566 | 1.74 | 82.3 | Palliative (P) | 2016-06-10 | 2016-06-10 | Carboplatin AUC 2 - 5 | N | N | 240033412 | CARBOPLATIN |
| 240007403 | 240013511 | 1.76 | 61.3 | Curative (C) | 2014-01-12 | 2014-01-17 | DA 3 + 10 | N | N | 240033415 | DA |
| 240007404 | 240004602 | 1.56 | 57 | null | 2015-06-15 | 2015-06-18 | SMILE | null | null | 240033416 | TRIAL |
| 240007405 | 240004603 | 1.62 | 54.4 | Curative (C) | 2015-07-22 | 2015-08-03 | Bendamustine +/- Prednisolone | Y | N | 240033420 | BENDAMUSTINE |
| 240007406 | 240004604 | 1.52 | 58.2 | Neo-adjuvant (N) | 2014-02-10 | 2014-07-07 | null | N | N | 240033428 | NOT MATCHED |
| 240007407 | 240004605 | null | 86 | Palliative (P) | 2014-11-21 | 2014-12-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | null | 240033435 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007408 | 240004606 | 0 | 117 | Palliative (P) | 2015-10-27 | 2015-10-27 | Trial Unspecified | 2 | N | 240033442 | TRIAL |
| 240007409 | 240004607 | 1.74 | 61 | Disease modification (D) | 2017-05-04 | 2017-05-06 | Chlorambucil + Pred + Rituximab | N | N | 240033449 | CHLORAMBUCIL + RITUXIMAB |
| 240007410 | 240010567 | 1.52 | 0 | Palliative (P) | 2018-11-14 | 2018-11-17 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033450 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007411 | 240004608 | null | null | Curative (C) | 2015-03-17 | 2015-04-13 | null | null | null | 240033451 | NOT MATCHED |
| 240007412 | 240004609 | 1.61 | 99.3 | Curative (C) | 2015-09-28 | 2015-10-02 | null | 2 | N | 240033458 | NOT MATCHED |
| 240007413 | 240004609 | null | 98.1 | Curative (C) | 2013-02-07 | 2013-02-08 | Chlorambucil | null | N | 240033458 | CHLORAMBUCIL |
| 240007414 | 240004610 | 1.57 | null | Adjuvant (A) | 2017-12-10 | 2017-12-15 | CARBOPLATIN + ETOPOSIDE | N | N | 240033467 | CARBOPLATIN + ETOPOSIDE |
| 240007416 | 240004612 | 1.8 | 71.6 | Curative (C) | 2017-02-13 | 2017-02-13 | Bendamustine +/- Prednisolone | N | N | 240033470 | BENDAMUSTINE |
| 240007417 | 240004612 | 1.66 | 64.7 | Curative (C) | 2017-06-09 | 2017-06-14 | AML Interim Guidelines FLA | Y | N | 240033470 | NOT MATCHED |
| 240007418 | 240004612 | 1.66 | null | Curative (C) | 2017-09-25 | 2017-10-26 | null | null | null | 240033470 | NOT MATCHED |
| 240007419 | 240004613 | 1.73 | null | Curative (C) | 2014-01-04 | 2014-01-04 | INTERLACE TRIAL | 2 | null | 240033480 | INTERLACE TRIAL |
| 240007420 | 240004614 | null | 78 | Palliative (P) | 2012-12-09 | 2013-12-31 | Chlorambucil | N | N | 240033485 | CHLORAMBUCIL |
| 240007421 | 240004614 | 1.7 | 61.1 | Palliative (P) | 2014-07-04 | 2014-07-08 | Carboplatin + Etoposide iv&po | 02 | N | 240033485 | CARBOPLATIN + ETOPOSIDE |
| 240007422 | 240004614 | 1.6 | null | Disease modification (D) | 2016-04-13 | 2016-04-14 | CHLORAMBUCIL + RITUXIMAB | null | null | 240033485 | CHLORAMBUCIL + RITUXIMAB |
| 240007423 | 240014919 | 1.68 | 0 | Neo-adjuvant (N) | 2014-07-10 | 2014-07-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240033499 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007424 | 240014919 | 1.72 | 49.9 | Palliative (P) | null | 2014-12-05 | R Chlorambucil | N | N | 240033499 | CHLORAMBUCIL + RITUXIMAB |
| 240007425 | 240004615 | 1.7 | 67.6 | Palliative (P) | 2017-07-31 | 2017-07-31 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033501 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007426 | 240010571 | 0 | 83.2 | Curative (C) | 2016-12-21 | 2017-01-12 | Carboplatin AUC 2 - 5 | N | N | 240033502 | CARBOPLATIN |
| 240007427 | 240004616 | 1.71 | 84.4 | null | 2016-12-22 | 2016-12-23 | Chlorambucil | 01 | Y | 240033503 | CHLORAMBUCIL |
| 240007428 | 240004617 | 1.57 | 53 | Palliative (P) | 2014-07-26 | 2014-08-28 | Carboplatin AUC 6 - 10 | Y | N | 240033506 | CARBOPLATIN |
| 240007429 | 240004618 | 1.7 | 58.9 | Palliative (P) | 2016-08-29 | 2016-09-06 | Chlorambucil | Y | N | 240033512 | CHLORAMBUCIL |
| 240007430 | 240004618 | 1.72 | 60.8 | Curative (C) | 2015-02-13 | 2015-02-14 | Trial Unspecified | 1 | N | 240033512 | TRIAL |
| 240007431 | 240004619 | null | null | null | null | 2016-11-30 | CARBOPLATIN + ETOPOSIDE | null | null | 240033516 | CARBOPLATIN + ETOPOSIDE |
| 240007432 | 240004620 | 1.58 | 56.5 | null | null | 2018-04-30 | BENDAMUSTINE | N | N | 240033518 | BENDAMUSTINE |
| 240007433 | 240004621 | 1.63 | null | Curative (C) | 2017-01-25 | 2017-01-27 | Chlorambucil | null | null | 240033519 | CHLORAMBUCIL |
| 240007434 | 240010573 | 1.6 | 54 | Disease modification (D) | 2017-06-01 | 2017-06-02 | Hydroxycarbamide | Y | N | 240033521 | HYDROXYCARBAMIDE |
| 240007435 | 240004622 | 1.67 | 95 | Curative (C) | 2015-07-22 | 2015-07-22 | Trial Unspecified | N | N | 240033523 | TRIAL |
| 240007436 | 240004623 | 1.87 | 71 | Palliative (P) | 2014-03-01 | 2014-03-18 | Bevacizumab+Carbo+Pacliaxel | 99 | N | 240033526 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007437 | 240004623 | null | 0 | Curative (C) | 2014-08-28 | 2014-09-09 | INTERLACE TRIAL | null | N | 240033526 | INTERLACE TRIAL |
| 240007438 | 240004624 | 1.65 | 43.2 | Palliative (P) | 2015-04-26 | 2015-05-06 | R Chlorambucil | 99 | N | 240033534 | CHLORAMBUCIL + RITUXIMAB |
| 240007439 | 240004624 | 1.59 | 75.6 | Palliative (P) | 2016-12-06 | 2016-12-08 | DA | 1 | N | 240033534 | DA |
| 240007440 | 240004625 | 1.74 | 85 | Palliative (P) | 2018-06-22 | 2018-06-23 | Chlorambucil | N | N | 240033540 | CHLORAMBUCIL |